Evidence map›Paper›PMID 30796839›Full record

ArticleToxicological sciences : an official journal of the Society of Toxicology2019

Molecular Mechanisms of Polybrominated Diphenyl Ethers (BDE-47, BDE-100, and BDE-153) in Human Breast Cancer Cells and Patient-Derived Xenografts.

Noriko Kanaya, Lauren Bernal, Gregory Chang, Takuro Yamamoto, Duc Nguyen, Yuan-Zhong Wang, June-Soo Park, Charles Warden, Jinhui Wang, Xiwei Wu and 4 more

Abstract read
In one paragraph

Article in Toxicological sciences : an official journal of the Society of Toxicology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Environmental Carcinogenesis at the Single-Cell Level.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2020
    Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Noriko KanayaDepartment of Cancer Biology, Beckman Research Institute of City of Hope, Duarte, California 91010.
Lauren BernalDepartment of Cancer Biology, Beckman Research Institute of City of Hope, Duarte, California 91010.
Gregory ChangDepartment of Cancer Biology, Beckman Research Institute of City of Hope, Duarte, California 91010.
Takuro YamamotoDepartment of Cancer Biology, Beckman Research Institute of City of Hope, Duarte, California 91010.
Duc NguyenDepartment of Cancer Biology, Beckman Research Institute of City of Hope, Duarte, California 91010.
Yuan-Zhong WangDepartment of Cancer Biology, Beckman Research Institute of City of Hope, Duarte, California 91010.
June-Soo ParkEnvironmental Chemistry Laboratory, Department of Toxic Substances Control, Berkeley, California 94710.
Charles WardenIntegrative Genomics Core, Beckman Research Institute of City of Hope, Duarte, California 91010.
Jinhui WangIntegrative Genomics Core, Beckman Research Institute of City of Hope, Duarte, California 91010.
Xiwei WuIntegrative Genomics Core, Beckman Research Institute of City of Hope, Duarte, California 91010.
Timothy SynoldDepartment of Cancer Biology, Beckman Research Institute of City of Hope, Duarte, California 91010.
Michele RakoffBreast Cancer Care & Research Fund, Los Angeles, California 90036.
Susan L NeuhausenDepartment of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California 91010.
Shiuan ChenDepartment of Cancer Biology, Beckman Research Institute of City of Hope, Duarte, California 91010.

Funding

Transgenic Mouse FacilityP30CA033572 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI XIWEI WU · 1985 to 2026
$86.3M
Menopausal transition - a window of susceptibility for the promotion of breast cancer by environmental exposuresU01ES026137 · NIEHS · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI CHEN, SHIUAN, NEUHAUSEN, SUSAN L. · 2015 to 2019
$4.8M
NCI NIH HHS P30 CA033572NIEHS NIH HHS U01 ES026137
6 · The paper itself

Abstract

Polybrominated diphenyl ethers (PBDEs) have been used as flame retardants in household materials. Their environmental persistence has led to continuous human exposure and significant tissue levels. Three PBDE congeners (BDE-47, BDE-100, and BDE-153) have been frequently detected in human serum. Although these compounds appear to possess endocrine disrupting activity, studies are largely missing to determine the biological mechanisms of PBDEs in breast cancer cells. Here, we assessed PBDE bioactivities with three complementary strategies: receptor binding/activity assays; nonbiased RNA-sequencing analysis using an estrogen-dependent breast cancer cell line MCF-7aroERE; and in vivo assessments using patient-derived xenograft (PDX) models of human breast cancer. According to the results from in vitro experiments, the PBDE congeners regulate distinct nuclear receptor signaling pathways. BDE-47 acts as a weak agonist of both estrogen receptor α (ERα) and estrogen-related receptor α (ERRα); it could stimulate proliferation of MCF-7aroERE and induced expression of ER-regulated genes (including cell cycle genes). BDE-153 was found to act as a weak antagonist of ERα. BDE-100 could act as (1) an agonist of aryl hydrocarbon receptor (AhR), inducing expression of CYP1A1 and CYP1B1 and (2) as a very weak agonist/antagonist of ERα. In vivo, a mixture of the three congeners with ratios detected in human serum was tested in an ER+ PDX model. The mixture exhibited estrogenic activity through apoptosis/cell cycle regulation and increased the expression of a proliferation marker, Ki-67. These results advance our understanding of the mechanisms of PBDE exposure in breast cancer cells.

Indexed as

AnimalsCell CycleEstrogen Receptor alphaFemaleHalogenated Diphenyl EthersHeterograftsHumansMCF-7 CellsMicePolybrominated BiphenylsReceptors, Aryl HydrocarbonReceptors, ProgesteroneSequence Analysis, RNA2,2',4,4'-tetrabromodiphenyl etherEstrogen Receptor alphaHalogenated Diphenyl Ethershexabrominated diphenyl ether 153pentabrominated diphenyl ether 100Polybrominated BiphenylsReceptors, Aryl HydrocarbonReceptors, ProgesteroneAhRbreast cancerERER+ERRPBDEPDXPR

Identifiers

PMID30796839
PMCPMC6542340

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.